Clinical Characteristics of Hearing Loss Caused by P2RX2 Gene Variants
Authors:
- Shogo OyamadaSOShogo Oyamada
- Shin-Ya NishioShin-Ya Nishio
- Takechiyo YamadaTYTakechiyo Yamada
- Hiroshi NakanishiHNHiroshi Nakanishi
- Kiyoshi OdaKOKiyoshi Oda
- Yohei HonkuraYHYohei Honkura
- Masaomi MotegiMasaomi Motegi
- Taku ItoTITaku Ito
- Naoko SakumaNSNaoko Sakuma
- Kozo KumakawaKKKozo Kumakawa
- Marina KobayashiMKMarina Kobayashi
- Hiroko MonobeHMHiroko Monobe
Open Access
Abstract
Background/Objectives: The P2RX2 gene encoding an ATP-gated ion channel purinoreceptor is a genetic cause of autosomal dominant non-syndromic hearing loss (DFNA41). P2RX2 is a rare causative gene and its detailed clinical characteristics remain unclear. Methods: In this study, we performed next-generation DNA sequencing analysis covering 158 genes previously reported to be associated with non-syndromic and syndromic hearing loss in 18,475 patients. Results: We identified 29 patients from 22 independent families carrying candidate P2RX2 variants. All of the patients showed late-onset progressive hearing loss. In addition, several cases showed asymmetric hearing deterioration. Among the 29 patients, 23 from 19 unrelated families carried the same c.1057G>A variant, which was identified as a founder mutation by SNP-based haplotype analysis. Conclusions: Our findings indicate that late-onset asymmetric progressive hearing deterioration is a characteristic/unique feature of P2RX2-associated hearing loss, which may be related to noise exposure. Our results may be useful in further clarifying the natural history of and optimizing the management strategies for P2RX2-related hearing loss.Keywords
Funding Information
- Ministry of Health Labour and Welfare (H29-Nanchitou(Nan)-Ippan-031, 20FC10148, 23FC10149)
- Japan Agency for Medical Research and Development (JP16kk0205010, JP18ek0109363, JP21ek0109542, JP24ek0109741)
This publication has 44 references indexed in Scilit:
- Novel Clinical Manifestation and Favorable Treatment Outcome of Cochlear Implant in a Chinese Family With Likely Pathogenic Variant of the P2RX2 GeneAmerican Journal of Medical Genetics Part A, 2024
- The genetic etiology of hearing loss in Japan revealed by the social health insurance-based genetic testing of 10K patientsHuman Genetics, 2021
- Progressive Dominant Hearing Loss (Autosomal Dominant Deafness‐41) and P2RX2 Gene Mutations: A Phenotype–Genotype StudyThe Laryngoscope, 2019
- Expert specification of the ACMG/AMP variant interpretation guidelines for genetic hearing lossHuman Mutation, 2018
- Simple and efficient germline copy number variant visualization method for the Ion AmpliSeq™ custom panelMolecular Genetics & Genomic Medicine, 2018
- The Clinical Next-Generation Sequencing Database: A Tool for the Unified Management of Clinical Information and Genetic Variants to Accelerate Variant Pathogenicity ClassificationHuman Mutation, 2017
- Comprehensive genetic testing in the clinical evaluation of 1119 patients with hearing lossHuman Genetics, 2016
- The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicineHuman Genetics, 2013
- ATP activates P2x receptors and requires extracellular Ca++ participation to modify outer hair cell nonlinear capacitancePflügers Archiv - European Journal of Physiology, 2008
- Immunohistochemical localization of adenosine 5`-triphosphate-gated ion channel P2X2 receptor subunits in adult and developing rat cochleaJournal of Comparative Neurology, 2000